Loss of EGFR confers acquired resistance to AZD9291 in an EGFR-mutant non-small cell lung cancer cell line with an epithelial–mesenchymal transition phenotype

被引：0
|
作者：
Jing Xu
Xiaoting Zhao
Dengfeng He
Jinghui Wang
Weiying Li
Yinghui Liu
Li Ma
Mei Jiang
Yu Teng
Ziyu Wang
Meng Gu
Jianbin Wu
Yue Wang
Wentao Yue
Shucai Zhang
机构：
[1] Capital Medical University,Department of Medical Oncology, Beijing Tuberculosis and Thoracic Tumor Research Institute/Beijing Chest Hospital
[2] Capital Medical University,Department of Cellular and Molecular Biology, Beijing Tuberculosis and Thoracic Tumor Research Institute/Beijing Chest Hospital
[3] 263 Clinical Department of General Hospital of Beijing Military Region,Department of Traditional Chinese medicine
[4] Capital Medical University,Central Laboratory, Beijing Obstetrics and Gynecology Hospital
来源：
Journal of Cancer Research and Clinical Oncology | 2018年 / 144卷
关键词：
AZD9291; Resistance; EGFR loss; NSCLC; Potential therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1413 / 1422
页数：9
相关论文
共 50 条
  • [1] Loss of EGFR confers acquired resistance to AZD9291 in an EGFR-mutant non-small cell lung cancer cell line with an epithelial-mesenchymal transition phenotype
    Xu, Jing
    Zhao, Xiaoting
    He, Dengfeng
    Wang, Jinghui
    Li, Weiying
    Liu, Yinghui
    Ma, Li
    Jiang, Mei
    Teng, Yu
    Wang, Ziyu
    Gu, Meng
    Wu, Jianbin
    Wang, Yue
    Yue, Wentao
    Zhang, Shucai
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (08) : 1413 - 1422
  • [2] AZD9291 in EGFR-mutant advanced non-small-cell lung cancer patients
    Remon, Jordi
    Planchard, David
    [J]. FUTURE ONCOLOGY, 2015, 11 (22) : 3069 - 3081
  • [3] Acquired epithelial-mesenchymal transition like feature in an EGFR-mutant lung cancer cell line with acquired resistance to erlotinib
    Suda, Kenichi
    Tomizawa, Kenji
    Osada, Hirotaka
    Sekido, Yoshitaka
    Yatabe, Yasushi
    Mitsudomi, Tetsuya
    [J]. CANCER RESEARCH, 2011, 71
  • [4] AZD9291 in TKI EGFR resistance in non-small cell lung cancer and the new concept of phase I trials
    Gil-Bazo, Ignacio
    Rolfo, Christian
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (01) : 85 - 88
  • [5] Clinical activity of the mutant-selective EGFR inhibitor AZD9291 in patients with EGFR inhibitor-resistant non-small cell lung cancer
    Jiang, Tao
    Zhou, Caicun
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2014, 3 (06) : 370 - 372
  • [6] AZD9291 in EGFR Inhibitor-Resistant Non-Small-Cell Lung Cancer
    Jaenne, Pasi A.
    Yang, James Chih-Hsin
    Kim, Dong-Wan
    Planchard, David
    Ohe, Yuichiro
    Ramalingam, Suresh S.
    Ahn, Myung-Ju
    Kim, Sang-We
    Su, Wu-Chou
    Horn, Leora
    Haggstrom, Daniel
    Felip, Enriqueta
    Kim, Joo-Hang
    Frewer, Paul
    Cantarini, Mireille
    Brown, Kathryn H.
    Dickinson, Paul A.
    Ghiorghiu, Serban
    Ranson, Malcolm
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (18): : 1689 - 1699
  • [7] Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M
    Thress, Kenneth S.
    Paweletz, Cloud P.
    Felip, Enriqueta
    Cho, Byoung Chul
    Stetsonl, Daniel
    Dougherty, Brian
    Lai, Zhongwu
    Markovets, Aleksandra
    Vivancos, Ana
    Kuang, Yanan
    Ercan, Dalia
    Matthews, Sarah E.
    Cantarini, Mireille
    Barrett, J. Carl
    Jaenne, Pasi A.
    Oxnard, Geoffrey R.
    [J]. NATURE MEDICINE, 2015, 21 (06) : 560 - 562
  • [8] AZD9291 activity in patients with EGFR-mutant advanced non-small cell lung cancer (NSCLC) and brain metastases: Data from Phase II studies
    Ahn, M. J.
    Tsai, C. M.
    Yang, J. C. H.
    Shepherd, F. A.
    Satouchi, M.
    Kim, D. W.
    Bazhenova, L.
    Hirashima, T.
    Rukazenkov, Y.
    Cantarini, M.
    Mann, H.
    Ramalingam, S. S.
    Mitsudomi, T.
    Jaenne, P. A.
    Goss, G. D.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S625 - S626
  • [9] Tackling Osimertinib Resistance in EGFR-Mutant Non-Small Cell Lung Cancer
    Blaquier, Juan Bautista
    Ortiz-Cuaran, Sandra
    Ricciuti, Biagio
    Mezquita, Laura
    Cardona, Andres Felipe
    Recondo, Gonzalo
    [J]. CLINICAL CANCER RESEARCH, 2023, 29 (18) : 3579 - 3591
  • [10] IGFBP7 overexpression promotes acquired resistance to AZD9291 in non-small cell lung cancer
    Tang, Xiaonan
    Mu, Jing
    Ma, Li
    Tan, Qifan
    Wang, Jinghui
    Tan, Jinjing
    Zhang, Shucai
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 571 : 38 - 45
12345